French Police Seize Euthanasia Drugs Bought in the US
 
 
 
 
 
 

French Police Seize Euthanasia Drugs Bought in the US

/ 05:20 AM October 17, 2019

French police carried out nationwide raids Tuesday to seize dozens of bottles of a suspected illegal barbiturate often used by people intent on performing assisted suicides or euthanasia in the US,  prosecutors said.

France’s right-to-die laws allow only so-called “passive” euthanasia for severely ill or injured patients, often by removing a person’s life support systems.

ADVERTISEMENT

It does not let ill or elderly people take their own life, which some religious groups denounce as “state-sponsored suicide.”

US authorities alerted French colleagues last July that several packages containing Nembutal, a brand name for the drug pentobarbital, had been discovered en route to France marked as cosmetics.

The drug, owned by the Danish firm Lundbeck, has been outlawed for human medical use in France since 1996.

“Produced by a Danish laboratory which has an exclusive license to make it in the United States, it is sometimes misused by people hoping to end their lives,” Paris prosecutor Remy Heitz said in a statement.

Investigators found 125 direct recipients of the barbiturate, and on Tuesday some 300 officers carried out raids in 18 regions across France.

Heitz said 130 bottles suspected of containing Nembutal were seized at 103 different sites, and analyses are planned.

He did not say if any people were arrested during the investigations or raids.


Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Don't miss out on the latest news and information.
TAGS: business
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.




We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.